Net profit of Glaxosmithkline Pharma declined 7.57% to Rs 145.86 crore in the quarter ended September 2011 as against Rs 157.81 crore during the previous quarter ended September 2010. Sales rose 4.40% to Rs 607.56 crore in the quarter ended September 2011 as against Rs 581.98 crore during the previous quarter ended September 2010.
| Particulars | Quarter Ended |
| | Sep. 2011 | Sep. 2010 | % Var. |
| Sales | 607.56 | 581.98 | 4 |
| OPM % | 30.13 | 37.11 | -19 |
| PBDT | 220.10 | 241.51 | -9 |
| PBT | 215.20 | 237.41 | -9 |
| NP | 145.86 | 157.81 | -8 |